Peptide aldehyde inhibitors of the kallikreins: an investigation of subsite interactions with tripeptides containing structural variations at the amino terminus.
A series of tripeptide aldehyde derivatives containing variations at the P3 subsite and the amino terminus has been prepared and evaluated for trypsin-like serine protease inhibition. These compounds exhibit strong in vitro inhibition of human plasma kallikrein (HPK), porcine pancreatic kallikrein (PPK) and human plasmin (HP). As suspected from an examination of a related crystal structure, the presence of a hydrophobic residue (adamantyl) at the amino terminus dramatically improves the binding to PPK. The adamantyl group, however, represents a peak in binding; larger residues cause the binding to be reduced, and thus are less well accommodated in this subsite. Although both HP and HPK also can accept large molecular volume at the amino terminus, they do not exhibit the same preference for large residues at this subsite that is demonstrated by PPK. Selectivity differences also are observed with P3 subsite substitution; with PPK preferring a bulky, but compact side-chain (t-butyl) and HP and HPK preferring a more extended (e.g. benzyl) group.
Procter and Gamble Company, Corporate Research Division, Miami Valley Laboratories, Cincinnati, Ohio 45253-8707, USA.
G S
GS
Garrett
P E
PE
Correa
S J
SJ
McPhail
K
K
Tornheim
J A
JA
Burton
D J
DJ
Eickhoff
G G
GG
Engerholm
J M
JM
McIver
D000447:Aldehydes / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites / Q000502:physiology; D001798:Blood Proteins / Q000378:metabolism; D006801:Humans; D007610:Kallikreins / Q000037:antagonists & inhibitors*; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D008968:Molecular Conformation; D015394:Molecular Structure; D010179:Pancreas / Q000201:enzymology; D010455:Peptides / Q000737:chemistry*; D015842:Serine Proteinase Inhibitors / Q000138:chemical synthesis*; D013552:Swine
D000447:Aldehydes; D001798:Blood Proteins; D010455:Peptides; D015842:Serine Proteinase Inhibitors; D007610:Kallikreins